Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference

Kodiak Sciences (Nasdaq: KOD) announced that CEO Victor Perlroth, M.D., will present at the 2026 Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026, at 11:40 a.m. ET (8:40 a.m. PT).

Rhea-AI Summary

Kodiak Sciences (Nasdaq: KOD) announced that CEO Victor Perlroth, M.D., will present at the 2026 Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026, at 11:40 a.m. ET (8:40 a.m. PT).

A live webcast and limited-time replay will be accessible via the company’s investor relations website.

Argus May 29 session

+1.63% close to close Open Argus

Details

News Market Reaction – KOD

On May 29, the first trading day after this news, KOD closed 1.63% above the previous close.

Data tracked by StockTitan Argus for the May 29 session.

Market Context

This announcement centers on investor-relations visibility, with Kodiak presenting at the Jefferies ...

Analysis

This announcement centers on investor-relations visibility, with Kodiak presenting at the Jefferies Global Healthcare Conference on June 4, 2026 at 11:40am ET. In the past six months, key value drivers have been late-stage retina trial readouts and earnings updates, which produced mixed price reactions. When assessing this type of news, investors typically monitor upcoming Phase 3 milestones, cash runway disclosures, and any new clinical data shared alongside conference presentations.

Key Figures

Conference date: June 4, 2026 Presentation time ET: 11:40am ET Presentation time PT: 8:40am PT

Conference date

June 4, 2026

Jefferies Global Healthcare Conference presentation date

Presentation time ET

11:40am ET

Scheduled KOD presentation slot at Jefferies 2026

Presentation time PT

8:40am PT

Pacific Time for Jefferies 2026 presentation

Historical Context

5 past events · Latest: May 07

5 events

1. May 07

   Earnings & pipeline

   24h Move

   -6.1%

   Q1 2026 financials with positive GLOW2 and pipeline progress but shares fell.

2. May 01

   Conference clinical data

   24h Move

   +1.1%

   Upcoming scientific conference talks highlighting KSI-101 clinical and preclinical advances.

3. Mar 31

   Earnings & strategy

   24h Move

   +12.3%

   Q4 and FY2025 results plus strong GLOW2 topline and capital raise details.

4. Mar 26

   Phase 3 topline

   24h Move

   +74.8%

   Positive GLOW2 Phase 3 diabetic retinopathy results positioning Zenkuda as BLA-ready.

5. Feb 04

   Phase 1b results

   24h Move

   -6.9%

   Announcement of final APEX Phase 1b data for KSI-101 ahead of conference presentation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PALO ALTO, Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that Victor Perlroth, M.D., Chief Executive Officer, will present at the 2026 Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026, at 11:40am ET (8:40am PT).

A live webcast of the presentation will be available on the "Events and Presentations" section of Kodiak's website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.

About Kodiak Sciences Inc. 

Kodiak Sciences (Nasdaq: KOD) is a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused on bringing new science to the design and manufacture of next-generation retinal medicines to prevent and treat the leading causes of blindness globally. We are developing a portfolio of three late-stage clinical programs: Zenkuda™ (tarcocimab tedromer), KSI-501 and KSI-101.

For more information, please visit www.kodiak.com. 

Kodiak^®, Kodiak Sciences^®, ABC^®, ABC Platform^®, ABCD™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

View original content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html

SOURCE Kodiak Sciences Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kodiak Sciences (KOD) present at the 2026 Jefferies Global Healthcare Conference?

Kodiak Sciences will present on Thursday, June 4, 2026, at 11:40 a.m. ET. According to the company, this appearance is part of the 2026 Jefferies Global Healthcare Conference in New York.

Who is presenting for Kodiak Sciences (KOD) at the 2026 Jefferies Global Healthcare Conference?

Kodiak Sciences will be represented by Victor Perlroth, M.D., Chief Executive Officer. According to the company, he will deliver the presentation during the scheduled conference session in New York.

How can investors watch the Kodiak Sciences (KOD) presentation at Jefferies 2026?

Investors can watch via a live webcast on Kodiak Sciences’ investor relations site. According to the company, it will appear under the “Events and Presentations” section and be available for replay for a limited time.

Will the Kodiak Sciences (KOD) Jefferies 2026 presentation be available for replay?

Yes, a replay will be available for a limited time after the event. According to the company, the replay can be accessed on the investor relations website under “Events and Presentations.”

What type of company is Kodiak Sciences (KOD) presenting at Jefferies 2026?

Kodiak Sciences is described as a precommercial retina-focused biotechnology company. According to the company, it is committed to researching, developing and commercializing transformative therapeutics for retinal diseases.